drugset / Trial / NCT03422887
Nalbuphine and Flurbiprofen for Oculoplastic Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the postoperative pain and discomfort using flurbiprofen axetil or nalbuphine administration after oculoplastic surgery under general anesthesia.
Timeline
- Start
- 2018-01-18
- Primary completion
- 2018-08-31
- Completion
- 2018-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nalbuphine | Small molecule | 0.1 mg/kg | — |
| Comparator | flurbiprofen axetil | Other / unclassified | 100 mg | — |
Indications
No indication recorded.